CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study

Noriyuki Enomoto; Shogo Nakai; Shusuke Yazawa; Yasutaka Mochizuka; Atsuki Fukada; Yuko Tanaka; Hyogo Naoi; Yusuke Inoue; Hideki Yasui; Masato Karayama; Yuzo Suzuki; Hironao Hozumi; Kazuki Furuhashi; Mikio Toyoshima; Masato Kono; Shiro Imokawa; Masato Fujii; Taisuke Akamatsu; Naoki Koshimizu; Koshi Yokomura; Hiroyuki Matsuda; Yusuke Kaida; Yutaro Nakamura; Masahiro Shirai; Kazutaka Mori; Masafumi Masuda; Tomoyuki Fujisawa; Naoki Inui; Hiroaki Sugiura; Hiromitsu Sumikawa; Masashi Kitani; Kazuhiro Tabata; Noriyoshi Ogawa; Takafumi Suda

doi:10.1186/s12931-024-02982-0

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Interstitial pneumonia with autoimmune features (IPAF), which does not meet any of the criteria for connective tissue diseases (CTD), has been attracting an attention in patients with idiopathic interstitial pneumonia (IIP). However, the biomarkers that reflect the clinical course of these patients have not been fully elucidated.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Enomoto et al. (2024) studied this question.

synapsesocial.com/papers/68e57186b6db643587512458 https://doi.org/10.1186/s12931-024-02982-0

View Full Paper

Ask AI

Bookmark

Share

CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study

Ask about this paper

Abstract

Discussion

Cite This Study

CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading